Status:
ACTIVE_NOT_RECRUITING
Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Danderyd Hospital
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation is a heart rhythm disorder with increased risk of stroke, heart failure, dementia and death. The severity of symptoms in atrial fibrillation varies markedly, ranging from no sympto...
Detailed Description
Atrial fibrillation is a heart rhythm disorder with increased risk of stroke, heart failure, dementia and death. The severity of symptoms in atrial fibrillation varies markedly, ranging from no sympto...
Eligibility Criteria
Inclusion
- Validation cohort:
- Patients undergoing direct current cardioversion successfully for treatment of atrial fibrillation or atrial flutter and have a normal heart rhythm after the treatment.
Exclusion
- Patients with implantable cardiac devices.
- Clinical implementation cohort:
- Inclusion Criteria:
- Patients planned for direct current cardioversion for treatment of atrial fibrillation or atrial flutter.
Key Trial Info
Start Date :
November 27 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04300270
Start Date
November 27 2018
End Date
April 1 2025
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danderyd University Hospital
Stockholm, Sweden, 182 88